Sobi
Social media
Swedish Orphan Biovitrum Logo
About Swedish Orphan Biovitrum
Swedish Orphan Biovitrum AB (Sobi) is an international biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of pharmaceuticals for rare and debilitating diseases. With a focus on haematology, immunology, and specialty care, Sobi offers innovative therapies for conditions such as haemophilia, paroxysmal nocturnal haemoglobinuria, thrombocytopenia, and hereditary tyrosinaemia type-1. The company collaborates with global partners and serves patients in Europe, North America, the Middle East, Asia, and Australia.
Address
TomtebodavAegen 23A,
Solna, 112 76
Sweden
Year founded
1939
Number of employees
1,000-2,000
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
